|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 9/1617 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/2077 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2086 | (2013.01) | ||
| A61K 9/24 | (2006.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 9/209 | (2013.01) | ||
| A61K 31/522 | (2006.01) | ||
| A61K 9/2095 | (2013.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61K 31/155 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/522 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Patento numeris | 3453403 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18195610.3 |
| Europos patento paraiškos padavimo data | 2009-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-01-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 08154039 | 2008-04-03 | EP | |
| 87343 P | 2008-08-08 | US |
| (72) |
FRIEDL, Thomas , DE
BRAUN, Michael , DE
EGUSA, Kenji , DE
FUJITA, Hikaru , DE
MARUYAMA, Megumi , JP
NISHIOKA, Takaaki , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION |
| DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION |